Clinical trial
Thelin (Sitaxentan Sodium) Patient Safety Registry A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin
NCT00995566 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thelin (Sitaxentan Sodium) Patient Safety Registry A Non-Interventional, Patient Registry For The Collection Of Pre-Defined Safety Data In Patients Prescribed Thelin
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Terminated
- Start date
- April 30, 2010
- Completion date
- February 28, 2011
- Enrollment
- 54 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.